Drug Profile
Olanexidine - Otsuka Pharmaceutical
Alternative Names: Olanedine; Olanexidine gluconate; OPB-2045; OPB-2045GLatest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Otsuka Pharmaceutical
- Class Antibacterials; Antifungals; Antiseptics; Biguanides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 18 Sep 2018 Otsuka completes enrolment in a phase II trial in Bacterial infections (Prevention, In infants, In adolescents, In children) in Japan (Topical) (UMIN000027899)
- 26 Jun 2017 Otsuka initiates enrolment in a phase II trial in Bacterial infections (Prevention, In infants, In adolescents, In children) in Japan (Topical) (UMIN000027899)
- 16 Sep 2015 Launched for Bacterial infections (Prevention) in Japan (Topical)